Gland Pharma Ltd.

Financial

	Gland Pharma	Caplin Point Lab	Gufic Biosciences
Operational Metrics
Pharmaceutical Sector
Number of ANDA's Filed in USA	372.0 .	51.0 .	n/a
Number of ANDA's Approved By USFDA	325.0 .	38.0 .	n/a
US DMF Filings	68.0 .	n/a	n/a
Unclassified
R&D as a % of Total Sales	4.4 %	3.52 %	1.28 %
API Capacity	11000.0 Kg/Year	n/a	n/a
Financials
5 yr Average ROE	12.02 %	19.84 %	25.05 %
5yr average Equity Multiplier	1.15	1.15	2.22
5yr Average Asset Turnover Ratio	0.51	0.68	1.05
5yr Avg Net Profit Margin	20.79 %	25.35 %	10.9 %
Price to Book	3.64	6.25	6.16
P/E	43.24	31.54	59.89
5yr Avg Cash Conversion Cycle	69.81 Days	70.68 Days	26.94 Days
Inventory Days	118.26 Days	66.07 Days	66.86 Days
Days Receivable	99.92 Days	110.7 Days	128.09 Days
Days Payable	107.43 Days	85.23 Days	163.91 Days
5yr Average Interest Coverage Ratio	183.05	633.04	13.1
5yr Avg ROCE	16.55 %	24.45 %	27.25 %
5yr Avg Operating Profit Margin	29.26 %	31.52 %	18.45 %
5 yr average Debt to Equity	0.01	0.0	0.51
5yr CAGR Net Profit	-6.87 %	17.23 %	14.26 %
5yr Average Return on Assets	10.65 %	17.23 %	11.52 %
Shareholdings
Promoter Holding	51.83 %	70.56 %	72.52 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-6.04 %	1.68 %	-2.48 %
Change in Mutual Fund Holding (3 Yrs)	15.13 %	0.87 %	2.35 %

Business

	Gland Pharma	Caplin Point Lab	Gufic Biosciences
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Injectables 0 Branded Generic 0 Generic 0 API 0 Muscle Relaxants 0 Cardiovascular 0 Proton pump inhibitors 0 Anti-fungals 0 Anti-bacterials 0 International 0 CMO 0 Domestic 0	Product Wise Break-Up Anti-fungals 0 Formulations 75.0 Muscle Relaxants 0 Branded Generics 25.0 Pharmaceutical 0 API 0 Anti-bacterials 0 Cardiovascular 0 CMO 0 Injectables 0 International 0 Domestic 0 Proton pump inhibitors 0	Product Wise Break-Up Anti-fungals 0 Generic 0 Muscle Relaxants 0 Branded Generic 0 Pharmaceutical 0 Active Pharmaceutical Ingredient (API) 5.0 Anti-bacterials 0 Cardiovascular 0 CMO 30.0 Injectables 0 International 15.0 Domestic Pharmaceuticals 50.0 Proton pump inhibitors 0
Location Wise Break-Up	Location Wise Break-Up USA 68.88 Europe 6.14 India 5.71 Canada, Australia & New Zealand 4.54 Australia 0 Canada 0 Africa 0 LATAM 0 South America 0 North America 0 Asia 0 Rest of the World 0 Others 14.73	Location Wise Break-Up Asia 0 Canada 0 Australia 0 North America 0 Rest of the World 0 Africa 6.0 USA 18.0 Canada, Australia & New Zealand 0 Latin America 76.0 South America 0 India 0 Europe 0	Location Wise Break-Up Asia Pacific 4.5 Canada 0 Australia 0.53 North America 1.27 Rest of the World 0 Africa 0.72 USA 0 Canada, Australia & New Zealand 0 LATAM 0 South America 0.23 India 89.07 Europe 3.67 Others 0.01
Distribution Channel	Distribution Channel B2B 99.0 B2C 1.0 Tender Business 0 Pharmacy Sales 0 Distributors 0	Distribution Channel Distribution 45.0 B2C 0 Tender Business 20.0 B2B 0 Pharmacy and Dietary 35.0	-

Gland Pharma Ltd.

SIGN UP FOR FREE